Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Faeth Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −2 vs. Q1 2022
- Shares held
- 3.11M
- −436.4K (−12.3%) vs. Q1 2022
- Total value
- $7.06M
- −$1.15M (−13.9%) vs. Q1 2022
- New holders
- 11
- 7 more added
- Sold out
- 13
- 16 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $72.2M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.5K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.45M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 723,549 | $1.64M | 0.04% | +723,549 | New |
| Vanguard Group Inc | 669,572 | $1.52M | 0.00% | −86,378−11.4% | Reduced |
| Newtyn Management, LLC | 415,000 | $942.0K | 0.18% | +415,000 | New |
| Renaissance Technologies LLC | 247,000 | $561.0K | 0.00% | +163,805+196.9% | Added |
| BlackRock Inc. | 178,894 | $406.0K | 0.00% | −989,117−84.7% | Reduced |
| Millennium Management LLC | 133,705 | $304.0K | 0.00% | +83,961+168.8% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $227.0K | 0.02% | 00.0% | Unchanged |
| Ergoteles LLC | 93,598 | $212.0K | 0.01% | +93,598 | New |
| Geode Capital Management, LLC | 91,895 | $208.0K | 0.00% | −163,933−64.1% | Reduced |
| Citadel Advisors LLC | 59,380 | $134.0K | 0.00% | +59,380 | New |
| HighTower Advisors, LLC | 50,229 | $114.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 41,100 | $93.0K | 0.00% | +200+0.5% | Added |
| Two Sigma Investments, LP | 38,776 | $88.0K | 0.00% | −23,408−37.6% | Reduced |
| Bridgeway Capital Management, LLC | 37,900 | $86.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 25,774 | $59.0K | 0.00% | −199,798−88.6% | Reduced |
| Morgan Stanley | 26,175 | $59.0K | 0.00% | +15,089+136.1% | Added |
| Truist Financial Corp | 19,934 | $45.0K | 0.00% | −30,507−60.5% | Reduced |
| Raymond James & Associates | 19,000 | $43.0K | 0.00% | +6,000+46.2% | Added |
| Qube Research & Technologies Ltd | 18,753 | $43.0K | 0.00% | +18,753 | New |
| Bank of America Corp | 16,871 | $38.0K | 0.00% | −31,130−64.9% | Reduced |
| Northern Trust Corp | 15,542 | $35.0K | 0.00% | −138,619−89.9% | Reduced |
| BFT Financial Group, LLC | 14,845 | $34.0K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 13,917 | $32.0K | 0.00% | +3,150+29.3% | Added |
| UBS Group AG | 13,463 | $31.0K | 0.00% | −155−1.1% | Reduced |
| D. E. Shaw & Co., Inc. | 12,901 | $29.0K | 0.00% | +12,901 | New |
| Goldman Sachs Group Inc | 11,056 | $25.0K | 0.00% | −1,621−12.8% | Reduced |
| Virtu Financial LLC | 11,223 | $25.0K | 0.00% | +11,223 | New |
| Tower Research Capital LLC (TRC) | 4,382 | $10.0K | 0.00% | −369−7.8% | Reduced |
| Banque Cantonale Vaudoise | 3,900 | $9.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,674 | $4.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,301 | $3.00K | 0.00% | −155,064−99.2% | Reduced |
| Citigroup Inc | 672 | $2.00K | 0.00% | −1,438−68.2% | Reduced |
| Wells Fargo & Company | 61 | $0 | 0.00% | −6,942−99.1% | Reduced |
| New York State Common Retirement Fund | 156 | $0 | 0.00% | −5,334−97.2% | Reduced |
| Barclays PLC | 196 | $0 | 0.00% | −3,198−94.2% | Reduced |
| FMR LLC | 199 | $0 | 0.00% | +20+11.2% | Added |
| Harbour Investments, Inc. | 3 | $0 | 0.00% | +3 | New |
| Credit Suisse AG | 11 | $0 | 0.00% | +11 | New |
| Capital Advisors, Ltd. LLC | 96 | $0 | 0.00% | +96 | New |
| Parallel Advisors, LLC | 162 | $0 | 0.00% | +162 | New |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −52,456−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −54,089−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −43,865−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −16,169−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −11,343−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −10,375−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −9,107−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,516−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −1,602−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,284−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |